Physician profile
Robert J Oliver
NPI 1114981032
$999.33
in general payments reported to CMS, 2019-2025
16 companies · $378 in 2025
The $378 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $267 · 2023: $45.83 · 2024: $309 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $285.65 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $174.64 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $75.94 | 2023-2025 | Spravato, Xarelto |
| Pfizer INC. | $64.48 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.02 | 2025 | Jardiance |
| Exact Sciences Corporation | $61.40 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $48.55 | 2024-2025 | Airsupra, Farxiga |
| Organon LLC | $42.40 | 2022 | |
| Mylan Specialty L.P. | $32.46 | 2022-2024 | Yupelri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.16 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $28.41 | 2022 | |
| Sobi, INC | $26.91 | 2022 | |
| Amarin Pharma, INC. | $22.76 | 2022 | |
| Sumitomo Pharma America, INC. | $15.24 | 2025 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $14.58 | 2024 | Voquezna |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $12.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.